Skip to main content
logo
Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
2.980
-0.160 (-5.10%)
At close: Apr 28, 2026, 4:00 PM EDT
2.995
+0.015 (0.50%)
After-hours: Apr 28, 2026, 4:10 PM EDT

Revenue by Segment

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Discovery and Preclinical Development
529.28M611.55M672.98M702.02M-
Discovery and Preclinical Development Growth
-13.45%-9.13%-4.14%--
Just - Evotec Biologics
259.59M186.62M108.45M49.43M-
Just - Evotec Biologics Growth
39.10%72.08%119.41%--
Intersegment Elimination
-496.00K-1.21M---139.12M
EVT Execute
----610.17M
EVT Execute Growth
----19.67%
EVT Innovate
----146.98M
EVT Innovate Growth
----37.58%
Total
788.37M796.97M781.43M751.45M618.03M
Total Growth
-1.08%1.99%3.99%21.59%23.38%

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
USA
431.51M445.86M459.42M407.75M-
USA Growth
-3.22%-2.95%12.67%--
Germany
25.29M32.90M34.13M58.90M-
Germany Growth
-23.13%-3.60%-42.04%--
France
19.86M19.91M32.01M32.27M-
France Growth
-0.28%-37.79%-0.83%--
United Kingdom
61.72M92.52M86.37M115.26M-
United Kingdom Growth
-33.28%7.12%-25.06%--
Switzerland
161.61M109.04M64.92M22.00K-
Switzerland Growth
48.21%67.95%295009.09%--
Rest of the World
77.09M82.28M95.15M126.70M-
Rest of the World Growth
-6.32%-13.53%-24.90%--
Unallocated
11.29M14.45M9.42M10.55M-
Unallocated Growth
-21.84%53.45%-10.75%--
Total
788.37M796.97M781.43M751.45M-
Total Growth
-1.08%1.99%3.99%--
Source: S&P Global Market Intelligence.